Fulcrum Therapeutics to Participate at the Upcoming BofA Securities 2022 Healthcare Conference
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical…
Month: May 2022
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
SANTA ANA, Calif., May 05, 2022 (GLOBE NEWSWIRE) — NKGen Biotech Inc., a biotechnology company…
Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022
LBS-008 (aka Tinlarebant) showed an acceptable safety profile in adolescent Stargardt disease (STGD1) subjects A…
Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809
Up to $100 million of non-dilutive capital from Oxford Finance LLC Extends expected cash runway…
Surrozen to Present at the BofA Securities 2022 Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the…
Ashvattha Therapeutics to Present at UBS Global Healthcare Conference 2022
REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Ashvattha Therapeutics, (“Ashvattha”), a clinical stage…
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
– Data from Ongoing CFT7455 Phase 1/2 Trial Presented at the American Association for Cancer…
Eyenovia to Report First Quarter 2022 Results on Thursday, May 12
Company to host an investor conference call and webcast at 4:30pm ET on that day…
Vor to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a clinical-stage cell…
Entera Bio Files Patent Applications for Inventions that Optimize its Platform Technology for Oral Delivery of Large Molecule Therapeutics
— Inventions aim to improve bioavailability and reduce drug costs — — Patent applications include…
Kymera Therapeutics to Share Novel Preclinical Findings Reinforcing the Advantage of IRAK4 Degraders over Kinase Inhibitors as well as First STAT3 Degrader Results in a Preclinical Model of Th17 Inflammation
-Data to be shared at the American Association of Immunologists (AAI) Annual Meeting -Results highlight…
Athira Mails Letter to Shareholders Emphasizing the Company’s Strong Position and Qualified Board as it Enters Pivotal Chapter
Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John…
Keros Therapeutics Reports First Quarter 2022 Financial Results
LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
IN8bio Unveils Induced Pluripotent Stem Cell (iPSC) Platform at ASGCT 25th Annual Meeting
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
Salarius Pharmaceuticals to Report First Quarter 2022 Financial Results and Highlight Recent Company Progress
Conference Call and Live Audio Webcast Scheduled for Thursday, May 12, 2022, 5:00 p.m. ET…
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on…
InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV
Study will use delta-9 dominant THCV manufactured by InMed’s subsidiary BayMedica Assesses key health outcomes…
Radius Health, Inc. First Quarter 2022 Results
Q1 2022 TYMLOS® product net revenue of $43 million vs. $45 million in Q1 2021°…
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists
Cytokine-Based Fusion Proteins to Activate and Expand Memory-Like NK Cells Without Using Feeder CellsSufficient for Off-the-Shelf…
SIGA Declares Special Dividend of $0.45 Per Share
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…